NASDAQ:MITI - Amgen Rockville Stock Price, Price Target & More

Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Amgen Rockville (NASDAQ:MITI)

Amgen Rockville logoDesigns and develops antibody-based drugs for treatment of cancer. The Company is a biotechnology company with a focus on the development of antibody-based products for cancer and inflammatory and autoimmune diseases. Micromet has established a drug development platform based on its BiTE technology, a drug format that leverages the cytotoxic potential of T cells.

Receive MITI News and Ratings via Email

Sign-up to receive the latest news and ratings for MITI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolNASDAQ:MITI
CUSIPN/A
Phone+1-240-7521420

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A

How to Become a New Pot Stock Millionaire

Amgen Rockville (NASDAQ:MITI) Frequently Asked Questions

What is Amgen Rockville's stock symbol?

Amgen Rockville trades on the NASDAQ under the ticker symbol "MITI."

Has Amgen Rockville been receiving favorable news coverage?

Headlines about MITI stock have trended positive this week, according to Accern Sentiment Analysis. Accern identifies negative and positive news coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Amgen Rockville earned a coverage optimism score of 0.35 on Accern's scale. They also assigned news headlines about the biotechnology company an impact score of 48.19 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the near term.

How do I buy shares of Amgen Rockville?

Shares of MITI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact Amgen Rockville?

Amgen Rockville's mailing address is 9201 Corporate Blvd Ste 400, ROCKVILLE, MD 20850-7209, United States. The biotechnology company can be reached via phone at +1-240-7521420.


MarketBeat Community Rating for Amgen Rockville (MITI)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  59 (Vote Outperform)
Underperform Votes:  57 (Vote Underperform)
Total Votes:  116
MarketBeat's community ratings are surveys of what our community members think about Amgen Rockville and other stocks. Vote "Outperform" if you believe MITI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MITI will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Amgen Rockville (NASDAQ:MITI) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
(Data available from 4/25/2016 forward)

Earnings

Amgen Rockville (NASDAQ:MITI) Earnings History and Estimates Chart

Earnings by Quarter for Amgen Rockville (NASDAQ:MITI)

Amgen Rockville (NASDAQ MITI) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/8/2011($0.23)($0.17)ViewN/AView Earnings Details
8/4/2011($0.21)($0.19)ViewN/AView Earnings Details
5/10/2011($0.17)($0.19)ViewN/AView Earnings Details
3/3/2011($0.15)($0.17)ViewN/AView Earnings Details
11/9/2010Q3 2010($0.19)($0.12)ViewN/AView Earnings Details
8/5/2010Q2 2010($0.17)($0.04)ViewN/AView Earnings Details
5/5/2010Q1 2010($0.17)($0.15)ViewN/AView Earnings Details
3/4/2010Q4 2009($0.18)($0.34)ViewN/AView Earnings Details
11/5/2009Q3 2009($0.14)($0.22)ViewN/AView Earnings Details
8/6/2009Q2 2009($0.14)($0.15)ViewN/AView Earnings Details
5/6/2009Q1 2009($0.10)($0.09)ViewN/AView Earnings Details
3/12/2009Q4 2008($0.16)($0.12)ViewN/AView Earnings Details
11/6/2008Q3 2008($0.14)($0.15)ViewN/AView Earnings Details
8/7/2008Q2 2008($0.14)($0.21)ViewN/AView Earnings Details
5/8/2008Q1 2008($0.13)($0.14)ViewN/AView Earnings Details
3/13/2008Q4 2007($0.13)($0.09)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Amgen Rockville (NASDAQ:MITI) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Amgen Rockville (NASDAQ MITI) Insider Trading and Institutional Ownership History

Insider Trading History for Amgen Rockville (NASDAQ:MITI)

Amgen Rockville (NASDAQ MITI) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
(Data available from 1/1/2013 forward)

Headlines

Amgen Rockville (NASDAQ MITI) News Headlines

Source:
No headlines for this company have been tracked by MarketBeat.com

SEC Filings

Amgen Rockville (NASDAQ:MITI) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Amgen Rockville (NASDAQ:MITI) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Amgen Rockville (NASDAQ MITI) Stock Chart for Wednesday, April, 25, 2018

Loading chart…

This page was last updated on 4/25/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.